Aug 2026· International Conference on Circuit, Power and Computing Technologies· pp. 617-621· 0 citations· 16 references
Abstract
The early detection of individuals with Mild Cognitive Impairment (MCI) who are at high risk of developing Alzheimer’s Disease (AD) is important for proper clinical intervention and disease management. Studies show that there is a strong link between brain age, which is estimated from brain scan data, and actual chronological age. This difference is called the Brain Age Gap (BAG), and it acts as a useful biological marker for identifying people at risk of brain degeneration. This study aims to create an automated dual-network framework that predicts MCI subjects’ likelihood of converting to AD based on their structural magnetic resonance imaging (MRI) brain scans. The two networks will consist of (i) a three-dimensional convolutional neural network (CNN) model that predicts an estimated brain age based on the inputted MRI scan of a subject, and (ii) a risk prediction network that predicts probability of MCI-to-AD conversion by incorporating estimated brain age, BAG, and deep feature representations. The framework will be trained in sequential order using a longitudinal neuroimaging dataset. Results from the experiment indicate higher classification performance can be attained with the proposed dual-network architecture over current state-of-the-art single-stage classification methods or models without brain age. Furthermore, these results strongly support the use of brain age-based predictive features for early prediction of AD risk. The proposed method offers a fully automated and clinically interpretable solution for supporting early diagnosis and personalized intervention planning in Alzheimer’s disease.
Alzheimer's disease is a progressive neurodegenerative disease that leads to memory loss, cognitive decline and brain atrophy. Mild Cognitive Impairment is the early transitional stage between normal ageing and Alzheimer's disease in which brain structural changes start to appear but daily life functioning is still pre...
J. Surya, C. Mai, Madhubala Myneni· International Conference Com...· 0 citations
The proposed 3D CNN accurately distinguished DAT from cognitively normal controls using amyloid PET imaging and showed promising performance across the AD continuum, supporting the potential of deep learning for early AD detection and clinical decision support.
Mitchell Edema, K. Popuri, Hyunwoo Lee et al.· Journal of Alzheimer's Disea...· 0 citations
Alzheimer's disease AD, also known as dementia, is a disease resulting from an irreversible brain disorder that can develop gradually as the patient ages. Its distinguishing features include cognitive decline, memory loss, and psychological problems. Early diagnosis of this disease becomes difficult due to the complexi...
Ali Kareem Obaid, Y. Farjami· Kufa journal of Engineering· 0 citations
An advanced DL-powered framework for the early prediction of AD using MRI data demonstrates high accuracy, robustness, and interpretability, supporting its potential for reliable early AD diagnosis in clinical settings.
K. V. S. V. Trinadh Reddy, Gundeboyina Srinivasalu, T. V. Rao et al.· Archives of Medical Research· 0 citations
Alzheimer's disease (AD) is a chronic neurodegenerative disease that severely affects cognitive functions, which results in a serious memory impairment accompanied by personality changes. An active examination, which is sensitive and effective on time, is a must. Cerebrospinal fluid (CSF), Magnetic Resonance Imaging (M...